NM_016203.4(PRKAG2):c.1687C>T (p.Gln563Ter) AND Hypertrophic cardiomyopathy
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Feb 5, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003996412.2
Allele description [Variation Report for NM_016203.4(PRKAG2):c.1687C>T (p.Gln563Ter)]
NM_016203.4(PRKAG2):c.1687C>T (p.Gln563Ter)
Condition(s)
- Name:
- Hypertrophic cardiomyopathy
- Synonyms:
- HYPERTROPHIC MYOCARDIOPATHY
- Identifiers:
- MONDO: MONDO:0005045; MeSH: D002312; MedGen: C0007194; Human Phenotype Ontology: HP:0001639
-
cytochrome oxidase subunit 1, partial (mitochondrion) [Lobocleta peralbata]
cytochrome oxidase subunit 1, partial (mitochondrion) [Lobocleta peralbata]gi|300370745|gb|ADJ99452.1|Protein
-
Lathronympha strigana genome assembly, chromosome: 19
Lathronympha strigana genome assembly, chromosome: 19gi|2440437263|emb|OX421920.1|Nucleotide
-
Achyrophorus rutea isolate RU1 internal transcribed spacer 1, partial sequence; ...
Achyrophorus rutea isolate RU1 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; and large subunit ribosomal RNA gene, partial sequencegi|1421407740|gb|MF405680.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024